Does USTEKINUMAB Cause Liver function test increased? 724 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 724 reports of Liver function test increased have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.9% of all adverse event reports for USTEKINUMAB.
724
Reports of Liver function test increased with USTEKINUMAB
0.9%
of all USTEKINUMAB reports
456
Deaths
455
Hospitalizations
How Dangerous Is Liver function test increased From USTEKINUMAB?
Of the 724 reports, 456 (63.0%) resulted in death, 455 (62.8%) required hospitalization, and 392 (54.1%) were considered life-threatening.
Is Liver function test increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 724 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Liver function test increased?
METHOTREXATE (3,839)
ADALIMUMAB (2,070)
ETANERCEPT (1,829)
LEFLUNOMIDE (1,521)
ABATACEPT (1,415)
TOCILIZUMAB (1,406)
RITUXIMAB (1,325)
SULFASALAZINE (1,263)
HYDROXYCHLOROQUINE (1,259)
TOFACITINIB (1,221)
Which USTEKINUMAB Alternatives Have Lower Liver function test increased Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE